SEC Form D · filed October 27, 2015
Artax Biopharma, Inc
Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.
People & firms on this filing (17)
Robert W. Armstrong, Ph.D · Cambridge, MADirectorDamia Tormo · Cambridge, MAExec · DirectorJavier Garcia · Cambridge, MADirectorGino W. Santini · Cambridge, MADirectorPeter B. Finn · Boston, MAExecRaj W. Parekh · Cambridge, MADirectorHenri W. Termeer · Centennial, CODirectorAfsaneh Beschloss · Washington, Washington, D.C.DirectorKathryn A. Hall · San Francisco, CAExecHenri W. Termeer · Centennial, CODirectorAntonio Sierra · Washington, Washington, D.C.Exec · DirectorKarim Fadel · Cambridge, MAExec · DirectorTwo Sigma Principals, LLC · New York, NYDirectorTwo Sigma Investments, LLC · NEW YORK, NYExec · DirectorMatthew W. Clary · CHICAGO, ILDirectorRaj W. Parekh · Cambridge, MADirectorHenri W. Termeer · Cambridge, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗